Treatment of severe infections with temocillin. Clinical and bacteriological evaluation
- PMID: 4029026
- DOI: 10.2165/00003495-198500295-00046
Treatment of severe infections with temocillin. Clinical and bacteriological evaluation
Abstract
Included in a study of the clinical efficacy of temocillin were 20 hospitalised female patients suffering from infections of the respiratory or urinary tract, septicaemia or an abscess. Clinical evaluation revealed fully effective treatment in all patients, and all pathogens identified were eliminated during therapy with no adverse reactions being observed.
Similar articles
-
Temocillin treatment of serious infections due to gram-negative bacilli in an intensive care unit.Drugs. 1985;29 Suppl 5:213-20. doi: 10.2165/00003495-198500295-00048. Drugs. 1985. PMID: 3896741
-
Temocillin in the treatment of serious gram-negative infections.Drugs. 1985;29 Suppl 5:191-3. doi: 10.2165/00003495-198500295-00041. Drugs. 1985. PMID: 3896739
-
Mezlocillin: role in management of infectious diseases.J Antimicrob Chemother. 1982 Jan;9 Suppl A:281-7. doi: 10.1093/jac/9.suppl_a.281. J Antimicrob Chemother. 1982. PMID: 6210680 No abstract available.
-
Selection of antimicrobial therapy in serious bacterial infections.Semin Drug Treat. 1972 Winter;2(3):259-74. Semin Drug Treat. 1972. PMID: 4617923 Review. No abstract available.
-
Current practices in antimicrobial dosing.Rev Infect Dis. 1981 Jan-Feb;3(1):12-8. doi: 10.1093/clinids/3.1.12. Rev Infect Dis. 1981. PMID: 7012994 Review.
Cited by
-
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study.JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac132. doi: 10.1093/jacamr/dlac132. eCollection 2023 Feb. JAC Antimicrob Resist. 2022. PMID: 36601547 Free PMC article.
-
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.Antibiotics (Basel). 2022 Apr 7;11(4):493. doi: 10.3390/antibiotics11040493. Antibiotics (Basel). 2022. PMID: 35453244 Free PMC article. Review.
-
Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failure.JAC Antimicrob Resist. 2024 Oct 17;6(5):dlae164. doi: 10.1093/jacamr/dlae164. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39421154 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical